NBY

1.09

2.83% 0.03

Vorhandelsmarkt: 1.08 -0.01 -0.92%

Novabay Pharmaceuticals Inc (NBY)

Überblick Nachrichten Preisverlauf Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.06

Offen:

$1.07

24-Stunden-Volumen:

47,047

Relative Volume:

0.04

Marktkapitalisierung:

$137.35M

Einnahmen:

$4.75M

Nettoeinkommen (Verlust:

$-7.83M

KGV:

5.0069

EPS:

0.2177

Netto-Cashflow:

$-7.24M

1W Leistung:

+6.86%

1M Leistung:

-0.91%

6M Leistung:

+82.58%

1J Leistung:

+91.26%

1-Tages-Spanne:

$1.01

$1.09

1-Wochen-Bereich:

$1.00

$1.11

52-Wochen-Spanne:

$0.46

$4.44

Novabay Pharmaceuticals Inc Stock (NBY) Company Profile

Firmenname

Novabay Pharmaceuticals Inc

Sektor

Healthcare (1131)

Branche

Biotechnology (632)

Telefon

510-899-8800

Adresse

2000 Powell Street, Suite 1150, Emeryville, CA

Mitarbeiter

Twitter

@NovaBayPharma

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

NBY's Discussions on Twitter

Vergleichen Sie NBY mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NBY Novabay Pharmaceuticals Inc	1.09	133.57M	4.75M	-7.83M	-7.24M	0.2177
VRTX Vertex Pharmaceuticals Inc	457.26	117.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	722.83	76.06B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.56	62.53B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	916.31	56.75B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	205.04	44.10B	447.02M	-1.18B	-906.14M	-6.1812

Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2019-09-18	Eingeleitet	Ladenburg Thalmann	Buy
2018-07-06	Bestätigt	H.C. Wainwright	Buy
2017-11-15	Bestätigt	Laidlaw	Buy
2017-06-05	Eingeleitet	ROTH Capital	Buy
2017-03-27	Eingeleitet	Laidlaw	Buy
2017-02-06	Eingeleitet	Rodman & Renshaw	Buy
2016-03-07	Herabstufung	Maxim Group	Buy → Hold
2015-12-14	Bestätigt	Maxim Group	Buy
2015-04-30	Fortgesetzt	Maxim Group	Buy
2013-03-06	Eingeleitet	Ascendiant Capital Markets	Strong Buy
2008-01-03	Eingeleitet	Dawson James	Speculative Buy

Alle ansehen

Novabay Pharmaceuticals Inc Aktie (NBY) Neueste Nachrichten

Dec 04, 2025

Is NovaBay Pharmaceuticals Inc. stock undervalued after correctionInsider Selling & Weekly Top Gainers Trade List - Newser

Dec 04, 2025

Will NovaBay Pharmaceuticals Inc. (B9P0) stock beat growth indexesQuarterly Market Review & Real-Time Stock Price Movement Reports - Newser

Dec 04, 2025

Why Did KALA BIO Shares Jump Over 22% After Hours? - Benzinga

Dec 04, 2025

Dec 03, 2025

Is NovaBay Pharmaceuticals Inc. stock dividend yield sustainableJuly 2025 Closing Moves & Proven Capital Preservation Tips - Newser

Dec 03, 2025

Dec 02, 2025

Why NovaBay Pharmaceuticals Inc. stock fits value portfoliosFed Meeting & Fast Gain Stock Trading Tips - Newser

Dec 02, 2025

Will NovaBay Pharmaceuticals Inc. stock recover faster than industryPortfolio Gains Summary & Safe Entry Momentum Stock Tips - Newser

Dec 02, 2025

Will NovaBay Pharmaceuticals Inc. (B9P0) stock announce a stock split2025 Dividend Review & Safe Capital Investment Plans - Newser

Dec 02, 2025

Can NovaBay Pharmaceuticals Inc. stock double in coming years2025 Price Momentum & Growth Oriented Trade Recommendations - Newser

Dec 02, 2025

Nov 27, 2025

How NovaBay Pharmaceuticals Inc. stock benefits from strong dollar - BỘ NỘI VỤ

Nov 27, 2025

Will NovaBay Pharmaceuticals Inc. stock outperform tech sector in 2025Quarterly Growth Report & Breakout Confirmation Alerts - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025

[S-8] NovaBay Pharmaceuticals, Inc. Employee Benefit Plan Registration | NBY SEC FilingForm S-8 - Stock Titan

Nov 26, 2025

What Sparked KALA BIO's Nearly 38% Surge Overnight? - Benzinga

Nov 26, 2025

Nov 25, 2025

[S-3/A] NovaBay Pharmaceuticals, Inc. Amended Shelf Registration Statement | NBY SEC FilingForm S-3/A - Stock Titan

Nov 25, 2025

Nov 21, 2025